References
- Champault G, Barrat C. Laparoscopy in the staging of cancer of the stomach. J Chir (Paris) 1999;136:150-155
- Davies J, Chalmers AG, Sue-Ling HM, May J, Miller GV, Martin IG, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 1997;41:314-309 https://doi.org/10.1136/gut.41.3.314
- Dux M, Richter GM, Hansmann J, Kuntz C, Kauffmann GW. Helical hydro-CT for diagnosis and staging of gastric carcinoma. J Comput Assist Tomogr 1999;23:913-922 https://doi.org/10.1097/00004728-199911000-00015
- Sendler A, Dittler HJ, Feussner H, Nekarda H, Bollschweiler E, Fink U, et al. Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg 1995;19:501-508 https://doi.org/10.1007/BF00294710
- Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997;204: 513-520 https://doi.org/10.1148/radiology.204.2.9240546
- Gryspeerdt S, Clabout L, Van Hoe L, Berteloot P, Vergote IB. Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer. Eur J Gynaecol Oncol 1998;19:434-437
- Boudiaf M, Bedda S, Soyer P, Panis Y, Zidi S, Kardache M, et al. Preoperative evaluation of gastric adenocarcinomas: comparison of CT results with surgical and patholgic results. Ann Chir 1999;53:115-122
- Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-332 https://doi.org/10.1148/radiol.2312021185
- Park DH, Kim KH, Park SY, Lee BH, Choi CW, Chin SY. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography. Korean J Radiol 2000;1:51-55 https://doi.org/10.3348/kjr.2000.1.1.51
- Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F] fluoro-2-deoxy-Dglucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-1035 https://doi.org/10.1053/jhep.2001.23912
- Tanaka T, Kawai Y, Kanai M, Taki Y, Nakamoto Y, Takabayashi A. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 2002;184:433-436 https://doi.org/10.1016/S0002-9610(02)01004-8
- Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 2003;44:1407-1412
- Buy JN, Moss AA, Ghossain MA, Sciot C, Malbec L, Vadrot D, et al. Peritoneal implants from ovarian tumors: CT findings. Radiology 1988;169:691-694 https://doi.org/10.1148/radiology.169.3.3186993
- Halvorsen RA Jr, Panushka C, Oakley GJ, Letourneau JG, Adcock LL. Intraperitoneal contrast material improves the CT detection of peritoneal metastases. AJR Am J Roentgenol 1991;157:37-40 https://doi.org/10.2214/ajr.157.1.2048534
- Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol 1988;150:1035-1041 https://doi.org/10.2214/ajr.150.5.1035
- Coakley FV, Choi PH, Gougoutas CA, Pothuri B, Venkatraman E, Chi D, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002;223:495-499 https://doi.org/10.1148/radiol.2232011081
- Lin EC, Lear J, Quaife RA. Metastatic peritoneal seeding patterns demonstrated by FDG positron emission tomographic imaging. Clin Nucl Med 2001;26:249-250 https://doi.org/10.1097/00003072-200103000-00020
- Fleiss J. Statistical methods for rates and proportions, 2nd ed. New York: Wiley, 1981;212-236
- Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxidesenhanced MR imaging. AJR Am J Roentgenol 1999;172:1547- 1554 https://doi.org/10.2214/ajr.172.6.10350287
- Blakeborough A, Ward J, Wilson D, Griffiths M, Kajiya Y, Guthrie JA, et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997;203:759-765 https://doi.org/10.1148/radiology.203.3.9169701
- Wang PH, Liu RS, Li YF, Ng HT, Yuan CC. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report. Gynecol Oncol 2000;77:44-47 https://doi.org/10.1006/gyno.2000.5738
- Sussman SK, Halvorsen RA Jr, Illescas FF, Cohan RH, Saeed M, Silverman PM, et al. Gastric adenocarcinoma: CT versus surgical staging. Radiology 1988;167:335-340 https://doi.org/10.1148/radiology.167.2.3357941
- Prayer L, Kainz C, Kramer J, Stiglbauer R, Schurawitzki H, Baldt M, et al. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer. J Comput Assist Tomogr 1993;17:626-632 https://doi.org/10.1097/00004728-199307000-00021
- Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003;30:288-295 https://doi.org/10.1007/s00259-002-1029-5
- Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with a, metastatic, or recurrent gastric cancer. J Nucl Med 2003;44:690- 699
- Ming SC. Gastric carcinoma. A pathobiological classification. Cancer 1977;39:2475-2485 https://doi.org/10.1002/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L
- Noda S, Soejima K, Inokuchi K. Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg 1980;10:277-283 https://doi.org/10.1007/BF02468788
- Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn 1982;32 Suppl 2:329-347
- De Potter T, Flamen P, Van Cutsem E, Penninckx F, Filez L, Bormans G, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002;29:525-529 https://doi.org/10.1007/s00259-001-0743-8